Lamotrigine in children and adolescents: the impact of age on its serum concentrations and on the extent of drug interactions
Lamotrigine in children and adolescents: the impact of age on its serum concentrations and on the extent of drug interactions
复制标题
儿童和青少年的拉莫三嗪:年龄对其血清浓度和药物相互作用程度的影响
DOI:
--
复制
发表时间:
2007
影响因子:
2.9
通讯作者:
O. Spigset
中科院分区:
文献类型:
--
作者:
Arne Reimers;E. Skogvoll;Janne Kutschera Sund;O. Spigset
ObjectiveTo investigate the impact of age and co-treatment with other drugs on the serum concentrations of lamotrigine in children and adolescents.MethodsA review of routine serum concentration measurements of lamotrigine performed in our laboratory yielded a total of 744 serum samples from 296 subjects (110 males, 186 females, age: 2–19 years) suitable for statistical analysis. The primary outcome variable was the dose-corrected lamotrigine serum concentration, expressed as the lamotrigine concentration/dose (C/D) ratio. A linear mixed model that allowed multiple observations from the same patient was used to identify and quantify the effect of factors influencing the lamotrigine C/D ratio.ResultsAccording to the model, the lamotrigine C/D ratio decreases by 6% per year of age. Valproate and levetiracetam were found to raise the lamotrigine C/D ratio, whereas the following co-medications reduced it: carbamazepine, clobazam, fluoxetine, clonazepam and ethinyl estradiol. The effect of carbamazepine decreased with increasing age. No gender difference was detected.ConclusionsAge is an important factor with respect to the pharmacokinetics and the extent of drug interactions of lamotrigine in children and adolescents. In this population, older individuals will need higher doses than younger ones in order to achieve the same serum concentrations.